Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating short-course radiation therapy with proton or photon beam and capecitabine with hydroxychloroquine in resectable pa…
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Results: XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for XB2001 in combination with ONIVYDE and 5-FU/LV (with or without folinic acid) in advanced pancreatic cancer have…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) [Phase 2]
Phase 2 trial evaluating high-dose ascorbate in pancreatic cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of ascorbic acid with NAB-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating antroquinonol in combination with standard of care in first-line metastatic pancreatic cancer; study completed wi…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]
Phase 2 trial assessing standard-of-care chemotherapy with or without stereotactic body radiation therapy for oligometastatic pancreatic can…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
Phase 2 trial results of a precision medicine approach (SMMART-ACT) in patients with advanced sarcoma, breast, ovarian, pancreatic, or prost…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 trial of daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active-not-recruiting, indicat…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Natural Killer Cells and Bortezomib to Treat Cancer [Phase 1]
This Phase 1 clinical trial update reports on the combination of natural killer cells and bortezomib for several cancers, and the study has …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating the combination of gemcitabine, capecitabine, and erlotinib in patients with advanced pancreatic cancer has been …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for locally advanced pancreatic cancer that cannot be removed su…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Pre-operative Treatment for Patients With Untreated Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant, pre-operative treatment for untreated pancreatic cancer, including both resectable and unresectable di…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors [NA]
This clinical trial update reports on prognostic and predictive biomarkers of therapeutic response in pancreatic tumors. The study sponsored…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer
A clinical trial evaluating pancreatic resection in fit octogenarians with nonmetastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors [Phase 2]
This Phase 2 trial update evaluates the efficacy and safety of tisotumab vedotin in solid tumors. It includes colorectal cancer, non-small c…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer [NA]
This entry reports that a clinical trial evaluating pre-operative stereotactic ablative body radiotherapy followed by immediate surgery for …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer [Phase 2]
This clinical trial update describes a Phase II study evaluating EvaluateBLEX 404 in combination with gemcitabine for pancreatic cancer, whi…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Intraoperative Endoscopic Ultrasound for Pancreatic Cancer [NA]
The clinical trial evaluating intraoperative endoscopic ultrasound for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer [Phase 2]
Phase 2 clinical trial investigating neoadjuvant therapy with gemcitabine, nab-paclitaxel, durvalumab, and oleclumab for resectable or borde…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating a dose-adjusted FOLFIRINOX regimen in elderly patients with metastatic pancreatic cancer reports efficacy and toler…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Supervised Prehabilitation Program for Patients With Pancreatic Cancer [NA]
This clinical trial update presents results from a supervised prehabilitation program for pancreatic cancer. Results were posted on 2026-04-…